开发和优化一种新型纳米载体SabiWhite载荷的体凝,用于针对性皮肤炎症的治疗,该炎症因多药耐药性病原体而复杂
Gaofeng Shi1, Yun Guo1, Minlie Yang1
1Burn and Trauma Treatment Center, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Frontiers in cellular and infection microbiology
|August 6, 2025
概括
沙比白载体 (SW-ETH) 显示出增强的局部抗炎作用和稳定性. 这种新型配方为皮肤炎症治疗提供了更好的生物相容性,这需要进一步的临床研究.
科学领域:
- 药理学和制药学 药理学和制药学
- 纳米技术在药物输送中的应用
- 皮肤病学 皮肤病学
背景情况:
- 乙基体配方为皮肤疾病提供了增强的药物输送.
- 萨比白是一种化合物,在皮肤炎症中具有潜在的治疗应用.
- 开发稳定和有效的局部输送系统对于SabiWhite的有效性至关重要.
研究的目的:
- 开发和评估 SabiWhite-loaded ethosomes (SW-ETH),用于局部应用.
- 为了提高SabiWhite的稳定性,生物相容性和治疗疗效.
- 为改善药物输送优化以太体配方参数.
主要方法:
- 使用适应的冷技术制备的以索姆配方 (SW-ETH).
- 32因数设计以优化脂和乙醇度.
- 通过点,FTIR,XRD进行表征;在小鼠体外药物释放和体内抗炎/皮肤刺激方面进行评估.
主要成果:
- 优化SW-ETH (SW-ETH 6) 的囊泡大小为184.4nm,捕获效率为92.5%.
- 持续的体外药物释放 (93.12%在24小时内) 和显著的体内抗炎活性 (36.17%抑制).
- 配方在120天内表现出极好的稳定性,并被归类为非刺激性.
结论:
- SW-ETH提供有效的SabiWhite封装和增强的局部抗炎活性.
- 该配方表现出优异的生物相容性,将其定位为有前途的局部治疗剂.
- 建议进行进一步的临床研究,以验证SW-ETH的治疗潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


